Marketable Securities, Current in USD of Protara Therapeutics, Inc. from Q1 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Protara Therapeutics, Inc. quarterly Marketable Securities, Current history and change rate from Q1 2021 to Q3 2025.
  • Protara Therapeutics, Inc. Marketable Securities, Current for the quarter ending 30 Sep 2025 was $120M, a 304% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Change (%)

Protara Therapeutics, Inc. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $120M +$90.4M +304% 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 $90.7M 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 $32.9M +$29.9M +1000% 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $7.49M -$18.5M -71.2% 31 Dec 2024 10-Q 10 Nov 2025
Q3 2024 $29.7M -$10.5M -26.1% 30 Sep 2024 10-Q 12 Nov 2024
Q1 2024 $2.99M -$62.6M -95.4% 31 Mar 2024 10-Q 02 May 2024
Q4 2023 $26M -$34.2M -56.9% 31 Dec 2023 10-K 05 Mar 2025
Q3 2023 $40.3M -$8.55M -17.5% 30 Sep 2023 10-Q 03 Nov 2023
Q2 2023 $46.4M -$18.3M -28.2% 30 Jun 2023 10-Q 03 Aug 2023
Q1 2023 $65.6M +$3.42M +5.5% 31 Mar 2023 10-Q 04 May 2023
Q4 2022 $60.2M +$4.74M +8.54% 31 Dec 2022 10-K 13 Mar 2024
Q3 2022 $48.8M -$4.2M -7.92% 30 Sep 2022 10-Q 03 Nov 2022
Q2 2022 $64.6M +$26.8M +70.9% 30 Jun 2022 10-Q 09 Aug 2022
Q1 2022 $62.2M +$36M +138% 31 Mar 2022 10-Q 05 May 2022
Q4 2021 $55.5M 31 Dec 2021 10-K 08 Mar 2023
Q3 2021 $53M 30 Sep 2021 10-Q 04 Nov 2021
Q2 2021 $37.8M 30 Jun 2021 10-Q 05 Aug 2021
Q1 2021 $26.1M 31 Mar 2021 10-Q 06 May 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.